JPWO2019147782A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019147782A5
JPWO2019147782A5 JP2020540798A JP2020540798A JPWO2019147782A5 JP WO2019147782 A5 JPWO2019147782 A5 JP WO2019147782A5 JP 2020540798 A JP2020540798 A JP 2020540798A JP 2020540798 A JP2020540798 A JP 2020540798A JP WO2019147782 A5 JPWO2019147782 A5 JP WO2019147782A5
Authority
JP
Japan
Prior art keywords
pyrrolidine
triazine
amino
trifluoromethyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020540798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021511363A (ja
JP7307734B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/014918 external-priority patent/WO2019147782A1/fr
Publication of JP2021511363A publication Critical patent/JP2021511363A/ja
Publication of JPWO2019147782A5 publication Critical patent/JPWO2019147782A5/ja
Application granted granted Critical
Publication of JP7307734B2 publication Critical patent/JP7307734B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020540798A 2018-01-26 2019-01-24 キナーゼ阻害剤としてのアミノピロロトリアジン Active JP7307734B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862622415P 2018-01-26 2018-01-26
US62/622,415 2018-01-26
PCT/US2019/014918 WO2019147782A1 (fr) 2018-01-26 2019-01-24 Aminopyrrolotriazines en tant qu'inhibiteurs de kinase

Publications (3)

Publication Number Publication Date
JP2021511363A JP2021511363A (ja) 2021-05-06
JPWO2019147782A5 true JPWO2019147782A5 (fr) 2022-01-28
JP7307734B2 JP7307734B2 (ja) 2023-07-12

Family

ID=65363405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020540798A Active JP7307734B2 (ja) 2018-01-26 2019-01-24 キナーゼ阻害剤としてのアミノピロロトリアジン

Country Status (16)

Country Link
US (1) US11618753B2 (fr)
EP (1) EP3743430B1 (fr)
JP (1) JP7307734B2 (fr)
KR (1) KR20200115550A (fr)
CN (1) CN112262139B (fr)
AR (1) AR114186A1 (fr)
AU (1) AU2019211382B2 (fr)
BR (1) BR112020014516A2 (fr)
CA (1) CA3088548A1 (fr)
EA (1) EA202091777A1 (fr)
ES (1) ES2959399T3 (fr)
IL (1) IL276269A (fr)
MX (1) MX2020007531A (fr)
SG (1) SG11202007035YA (fr)
TW (1) TW201940485A (fr)
WO (1) WO2019147782A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019016635A2 (pt) 2017-02-13 2020-04-07 Bristol-Myers Squibb Company aminotriazolopiridinas como inibidores da cinase
PL3704118T3 (pl) 2017-10-30 2022-04-04 Bristol-Myers Squibb Company Aminotriazolopirydazyny jako inhibitory kinaz
JPWO2021157596A1 (fr) * 2020-02-07 2021-08-12
JP2023533771A (ja) * 2020-07-10 2023-08-04 ベイジン ファインドキュア バイオサイエンシーズ リミテッド トリアジン系化合物およびその組成物と用途
CN111925345B (zh) * 2020-08-21 2023-09-29 上海科利生物医药有限公司 一种手性2-氨甲基四氢呋喃的制备方法
AR123793A1 (es) 2020-10-19 2023-01-11 Bristol Myers Squibb Co Compuestos de triazolopiridinilo como inhibidores de quinasas
WO2022172889A1 (fr) * 2021-02-10 2022-08-18 セントラル硝子株式会社 Composition de résine, film de résine, matériau de base, polymère et monomère polymérisable
CN113563214B (zh) * 2021-07-06 2024-02-02 山东鲁泰控股集团有限公司石墨烯高分子复合材料研发中心 一种氨基乙酸的合成方法
CN113527220A (zh) * 2021-07-26 2021-10-22 京博农化科技有限公司 一种脱硫丙硫菌唑异构体的合成方法
CN114989079B (zh) * 2022-06-21 2023-06-23 中国药科大学 Ripk1激酶靶点抑制剂及其医药用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007056170A2 (fr) 2005-11-02 2007-05-18 Bayer Healthcare Ag Derives pyrrolo-[2,1-f]-[1,2,4]-triazin-4-ylamines inhibiteurs de la igf-1r kinase pour le traitement des cancers et autres maladies hyperproliferatives
BRPI0618622A2 (pt) * 2005-11-17 2011-09-06 Osi Pharm Inc composto, composição, e, uso de um composto
PE20070855A1 (es) 2005-12-02 2007-10-14 Bayer Pharmaceuticals Corp Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas
WO2007064931A2 (fr) 2005-12-02 2007-06-07 Bayer Healthcare Llc Derives substitues de 4-amino-pyrrolotriazine utiles dans le traitement de troubles hyperproliferatifs et de maladies associees a l'angiogenese
WO2009046448A1 (fr) * 2007-10-04 2009-04-09 Intellikine, Inc. Entités chimiques et leurs utilisations thérapeutiques
WO2010126960A1 (fr) 2009-04-29 2010-11-04 Locus Pharmaceuticals, Inc. Composés de pyrrolotriazine
TW201107329A (en) * 2009-07-30 2011-03-01 Oncotherapy Science Inc Fused imidazole derivative having ttk inhibitory action
EP3070077B1 (fr) 2009-10-06 2018-11-28 Millennium Pharmaceuticals, Inc. Composés hétérocycliques utiles comme inhibiteurs de pdk1
US8791257B2 (en) * 2010-03-31 2014-07-29 Bristol-Myers Squibb Company Substituted pyrrolotriazines as protein kinase inhibitors
EP2897949B1 (fr) 2012-09-18 2018-01-10 Bristol-Myers Squibb Company Antagonistes d'iap
WO2015054358A1 (fr) 2013-10-11 2015-04-16 Bristol-Myers Squibb Company Inhibiteurs de pyrrolotriazine kinase
EP3209665B1 (fr) * 2014-10-22 2019-08-14 Bristol-Myers Squibb Company Composés pyrrolotriaziniques aminés substitués en tant qu'inhibiteurs de pi3k
US10214537B2 (en) 2014-10-22 2019-02-26 Bristol-Myers Squibb Company Bicyclic heteroaryl amine compounds
SI3436461T1 (sl) 2016-03-28 2024-03-29 Incyte Corporation Pirolotriazinske spojine kot tam-inhibitorji
WO2018017435A1 (fr) 2016-07-22 2018-01-25 Accro Bioscience Inc. Composés hétéroaryliques utilisés comme inhibiteurs de la nécrose, composition et application associées
BR112019016635A2 (pt) 2017-02-13 2020-04-07 Bristol-Myers Squibb Company aminotriazolopiridinas como inibidores da cinase
PL3704118T3 (pl) 2017-10-30 2022-04-04 Bristol-Myers Squibb Company Aminotriazolopirydazyny jako inhibitory kinaz
BR112021004385A2 (pt) 2018-09-13 2021-07-20 Bristol-Myers Squibb Company 1h-indazol carboxamidas como inibidores de proteína quinase de interação com o receptor 1 (ripk1)
US20210309633A1 (en) 2018-09-13 2021-10-07 Bristol-Myers Squibb Company Indazole carboxamides as kinase inhibitors

Similar Documents

Publication Publication Date Title
JP4740151B2 (ja) ケモカイン受容体のモジュレーターとしての3‐シクロアルキルアミノピロリジン誘導体
RU2427572C2 (ru) N-(1-(1-бензил-4-фенил-1н-имидазол-2-ил)-2,2-диметилпропил)бензамидные производные и родственные соединения в качестве ингибиторов кинезинового белка веретена (ksp) для лечения рака
KR101245918B1 (ko) 칸나비노이드 수용체 1 활성의 억제제로서 화합물 및 조성물
KR100895968B1 (ko) 케모킨 수용체의 조절자로서의 3-아미노피롤리딘 유도체
JP5658157B2 (ja) 置換ピロリジン−2−カルボキサミド
JP2019533694A5 (fr)
CA2469821A1 (fr) Modulateurs triazole substitues par heteroaryle du recepteur metabotropique 5 du glutamate
US20100210636A1 (en) Benzoxazinone derivative
RU2016137674A (ru) Производные пиперидиндиона
JPWO2019147782A5 (fr)
JP2018530591A5 (fr)
JP2006509715A5 (fr)
KR20140127238A (ko) 시클로알칸 유도체
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
JP2017500364A5 (fr)
JP2006516145A5 (fr)
CA2440238A1 (fr) Nouvelles amines en tant que ligands des recepteurs de l'histamine 3 et leurs applications therapeutiques
JP2009544626A (ja) Itpkb阻害剤としての化合物および組成物
RU2015144485A (ru) Геминально-замещенные цианоэтилпиразолопиридоны в качестве ингибиторов janus киназ
RU2014147191A (ru) Амидопроизводные как блокаторы ttx-s
RU2006135486A (ru) Производные n-пиперидина в качестве модуляторов ссr3
JP2016514709A5 (fr)
CA2905530A1 (fr) Inhibiteurs de pyrrolo[2,3-b]pyridine cdk9 kinase
US20130040932A1 (en) Substituted aryl sulfone derivatives as calcium channel blockers
RU2019117556A (ru) Индазольные производные, пригодные в качестве ингибиторов диацилглицерид o-ацилтрансферазы 2